Tags |
|
|
Links |
|
|
Just Answers - Find a Literary Agent: What's Your Competition?
Most aspiring authors begin their careers with little or no understanding of how to find a literary agent to represent their work. They quickly learn that most major publishing houses only accept
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
submissions through literary agents. So, they begin sending query letters to agents and, usually, meet with a cool reception, or even hit a high, solid, impenetrable brick wall. We surveyed over
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
60 literary agents, from both large well-known agencies as well as smaller “boutique” agencies, to get a perspective on how authors can improve their chances of attracting an agent, and to find o
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
ut the outlook for new authors trying to crack into the publishing industry.
To help writers find a literary agent, we asked the agents: How much competition does a new author really face? What
To help writers find a literary agent, we asked the agents: How much competition does a new author really face? What
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
Is The Most Common Reason You Decline To Represent A Writer?
In order to obtain the most candid comments possible, we told the agents their responses to our questions would not be attributed to
In order to obtain the most candid comments possible, we told the agents their responses to our questions would not be attributed to
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
hem (and as a result they were even more candid than we expected).
How Much Competition Does A New Author Really Face?
Unfortunately, the response was: a tremendous amount. The agents r
How Much Competition Does A New Author Really Face?
Unfortunately, the response was: a tremendous amount. The agents r
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
eported that they receive, on average, 90 unsolicited submissions per week. Out of these more than 4,500 submissions that come in each year, the agents, on average, took on 11 new clients. This m
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ans that the typical agent agreed to represent a little more than 2 out of 1000 of the authors that contacted them with unsolicited submissions. Regarding the 998 authors who did not receive a co
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
tract, we asked the agents:
What Is The Most Common Reason You Decline To Represent A Writer?
Poor writing 60%
Book was outside the agent’s genre 17%
Agent’s client bas
What Is The Most Common Reason You Decline To Represent A Writer?
Poor writing 60%
Book was outside the agent’s genre 17%
Agent’s client bas
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
e was full 10%
Writer’s work and agent don’t click 8%
Other 5%
The good news is that the top two reasons given are factors that are under the write
Writer’s work and agent don’t click 8%
Other 5%
The good news is that the top two reasons given are factors that are under the write
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
’s control. Most authors develop and improve their craft over a number of years, and even bestselling authors say when they were first starting out their initial literary efforts left something t
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
be desired. A dedicated writer certainly doesn’t have to remain in that “poor writing” category.
But what exactly is “poor writing”? In the decline letters they send to authors, agents often s
But what exactly is “poor writing”? In the decline letters they send to authors, agents often s
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
ay they turned the author down because they aren’t enthusiastic enough about the material. A favorite phrase used by agents in turndown letters is, “I simply didn’t fall in love with the writing.
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
This is probably the source of more author frustration than any other aspect of trying to get published. Success or failure hinges on extremely subjective judgments, and once the judgment is ren
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ered, it is final. Talking an agent out of an opinion is pretty much impossible. Think about your own reading experience. How often do you pick up a novel, read 10 pages, decide you aren’t intere
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
sted in it, and put it down? Does that mean the writing was “poor”? Not at all. It simply means you didn’t connect with the story, for reasons you may not even be able to articulate. Every indiv
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
dual’s literary taste is different.
One frequently received type of rejection isn’t really ‘rejection’ at all: The agent has all the clients they can handle at the present time, so they really h
One frequently received type of rejection isn’t really ‘rejection’ at all: The agent has all the clients they can handle at the present time, so they really h
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
ve no choice but to send a decline letter to unsolicited submissions. The agent in this case was doing the author a favor; far worse it would have been to accept a new client that would not get t
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
he necessary attention from the agent. Too often, though, authors interpret receiving a decline letter such as this as, “my book must not be any good.” Actually, the agent may not even had time t
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
read your submission package.
Notice that the fact a writer was unpublished was not a significant reason for being rejected as a client.
Hope this helps you find a literary agent for your work
Notice that the fact a writer was unpublished was not a significant reason for being rejected as a client.
Hope this helps you find a literary agent for your work
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.justanswers.org.ua/article/157820/justanswers-Find-a-Literary-Agent--Whats-Your-Competition.html">Find a Literary Agent: What's Your Competition?</a>
BB link (for phorums):
[url=http://www.justanswers.org.ua/article/157820/justanswers-Find-a-Literary-Agent--Whats-Your-Competition.html]Find a Literary Agent: What's Your Competition?[/url]
Related Articles:
Email Internet Marketing – Get Started With Email Marketing
Debt And The Risk Of Bankruptcy
Auto Insurance St. Louis - Finding a Low Rate
Bookmark it:
|